Switzerland-based Vifor Pharma Group is to be acquired by CSL Ltd of Australia for CHF 10.9 billion ($11.7 billion) creating one of the largest companies in nephrology and cardio-renal therapies. The merger comes less than a month after Vifor itself purchased two smaller companies.
